N-Benzyl-2-[(3-phenyl-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamide

ID: ALA2299081

PubChem CID: 47082775

Max Phase: Preclinical

Molecular Formula: C25H19N5O2S

Molecular Weight: 453.53

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(CSc1nc2ccccc2c2nc(=O)c(-c3ccccc3)nn12)NCc1ccccc1

Standard InChI:  InChI=1S/C25H19N5O2S/c31-21(26-15-17-9-3-1-4-10-17)16-33-25-27-20-14-8-7-13-19(20)23-28-24(32)22(29-30(23)25)18-11-5-2-6-12-18/h1-14H,15-16H2,(H,26,31)

Standard InChI Key:  CEOVDBDFBFZMGQ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   10.4902  -21.8332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4891  -22.6606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2038  -23.0735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2021  -21.4205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9175  -21.8296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9163  -22.6581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3490  -21.8316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6315  -21.4141    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0645  -21.4209    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   14.7780  -21.8351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4935  -21.4243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2070  -21.8386    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4954  -20.5993    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.9224  -21.4278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3479  -22.6601    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6294  -23.0708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6259  -23.8938    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3391  -24.3124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0576  -23.9016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0629  -23.0724    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3345  -25.1374    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.7699  -24.3179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6359  -21.8420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6285  -22.6677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3412  -23.0818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0576  -22.6710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0569  -21.8417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3437  -21.4313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7636  -25.1426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4750  -25.5589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1927  -25.1501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1945  -24.3209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4824  -23.9084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5  8  1  0
  6 16  1  0
 15  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 15 16  1  0
 15 20  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 18 21  2  0
 19 22  1  0
 14 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 22 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 22  1  0
M  END

Associated Targets(Human)

BT-549 (31254 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UO-31 (46270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A498 (42825 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNB-75 (44215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-62 (47048 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
786-0 (47912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-3 (48710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-435 (38290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LOX IMVI (44321 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-295 (48000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-268 (49410 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SW-620 (52400 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KM12 (47707 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLT-4 (49676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60(TB) (4309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-92 (41141 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SR (39847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-251 (51189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Photobacterium leiognathi (382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 453.53Molecular Weight (Monoisotopic): 453.1259AlogP: 3.71#Rotatable Bonds: 6
Polar Surface Area: 89.25Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 0.85CX LogP: 4.17CX LogD: 4.17
Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.24Np Likeness Score: -1.77

References

1. Kovalenko SI, Nosulenko IS, Voskoboynik AY, Berest GG, Antipenko LN, Antipenko AN, Katsev AM.  (2013)  Novel N-aryl(alkaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides: synthesis, cytotoxicity, anticancer activity, COMPARE analysis and docking,  22  (6): [10.1007/s00044-012-0257-x]

Source